Trial intelligence / Profile preview

Magnesium sulfate as adjuvant to ropivacaine for popliteal sciatic nerve block in hallux valgus surgery

2013-004863-30Phase 3Active

Sponsor
Università Campus Bio-Medico di Roma
Start
Dec 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of magnesium sulfate in bunion deformity (HAV) (2 arms), sponsored by Università Campus Bio-Medico di Roma. Primary endpoint: Primary efficacy of magnesium sulfate as local anesthetic adjuvant. Started Dec 2013; status: active.

02

Drugs

magnesium sulfate
03

Conditions

bunion deformity (HAV)

Beyond the preview

Go deeper on 2013-004863-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-004863-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call